ArticleNanotechnology, science and applications2025
Diamond Nanoparticles Suppress Migration of T98G Glioblastoma Cells by Targeting ECM-Integrin Interactions and Intracellular Signaling, Leading to Extensive Proteome Alterations.
Article in Nanotechnology, science and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Glioblastoma (GBM) is a highly heterogeneous and aggressive tumor characterized by rapid growth and therapy resistance. The dynamic interactions of tumor cells with the extracellular matrix (ECM) contribute to treatment inefficacy. While diamond nanoparticles (NDs) are emerging as potential antitumor agents, their mechanisms remain incompletely understood. In this study, we investigated spherical NDs with distinct surface compositions and hydrocolloidal stability and their role in regulating crucial cellular processes in T98G glioblastoma cells. Methods: Two types of detonation diamond nanoparticles (NDs) were characterized using TEM imaging and hydrocolloidal stability assessment in various diluents. Their effects on T98G glioblastoma cells were examined through SEM imaging, cytotoxicity assays, monitoring of spontaneous and collective migration, and early adhesion examination combined with an extensive integrin-blocking panel. Furthermore, characterization via mass spectrometry provided deeper insight into how physicochemical differences between the two NDs types modulate glioblastoma microenvironment and cell responses. Results: NDs were observed to be both intensively internalized by cells and bound to cell membrane, influencing cellular interactions with the extracellular environment. NDs significantly reduced T98G glioblastoma cell migration within 48 hours and impaired early adhesion by effectively blocking α/β integrins. Modified NDs (NDM) demonstrated enhanced hydrocolloidal stability and stronger integrin blocking efficiency. Proteomic analysis revealed that NDs downregulated proteins involved in RNA processing, splicing, and translation while upregulating ECM-related proteins, which profile changed depending on the NDs type. Conclusion: These findings suggest that NDs with distinct surface properties may interact with multiple surface receptors, independently modulate intracellular signaling pathways, and remodel the tumor microenvironment by altering ECM protein composition, positioning them as versatile, multi-targeting agents with antitumor potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.